When a room of physicians at ASH 2024 was asked whether they had prescribed a gene therapy in a commercial context, only a handful said yes.

Patients report zero bleeding in clinical trial conducted by CMC, Vellore and the Center for Stem Cell Research, Bengaluru.

Health minister Dzulkefly Ahmad says they are committed to ensuring a sufficient supply of drugs to treat those with this ...

Indian scientists successfully use gene therapy to treat severe haemophilia A, a rare hereditary condition with promising ...

The haemophilia community in Maharashtra is facing an alarming crisis as life-saving medications, including Factor VIII, Factor IX, Factor VII, and APCC for inhibitor patients, remain unavailable in ...

Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal ...

A single-centre study, which enrolled five participants aged between 22 and 41 years, showed transformational results ...

The 2nd Annual General Meeting of the Biotechnology Research and Innovation Council (BRIC) Society was held today under the ...

The Botswana Inherited Bleeding Disorders Association (BIBDA) is set to host a camp to impart knowledge on haemophilia, which ...

More than RM85mil has been spent to procure 18 types of haemophilia treatment medication between Jan 1 and Oct 30 of this ...

The Haemophilia Society described the situation as "unacceptably cruel" and called for the government to apologise. Kim ...

In the groundbreaking study the researchers observed an annualised zero bleeding rate in all the five subjects enrolled with ...